CFAs_0920202

Embed Size (px)

Citation preview

  • 8/8/2019 CFAs_0920202

    1/2

    Carrying and forwarding Agents/Depots/Distributors

    Distribution accounts for almost 35 percent of the retail cost of a drug. Yet, it hasn't witnessed much

    change unlike manufacturing and R&D in the past decade. The reasons are regulatory impediments

    (for instance, the sluggish implementation of VAT), and highly fragmented nature of the distribution

    network. But now, the distribution network is on the brink of a makeover. With the introduction of

    VAT in most states, the squeeze on domestic margins and increasing government pressure to contain

    retail drug prices, the reform in the distribution of Indian pharma is imminent, says a report by E&Y

    on Indian pharma distribution. The report, 'Reforms in distribution (Health Quotient)' has

    prophesised that the next wave of reform in the Indian pharma sector would be in the distribution

    network.

    Current State of CFA

    The existing pharma distribution setup is highly fragmented as it is based on the two-tier sales tax

    structure, namely central sales tax (CST) and local sales tax. To avoid CST, pharma companies have

    a C&F Agent (CFA), and company depot in each state to transfer goods as inter-state stock transfer.

    According to R B Puri, President of All India Organisation of Chemists and Druggists (AIOCD),

    the government will remove CST in next three to four years when VAT is implemented across the

    country, ushering in a massive change in the distribution network. With VAT, all transactions will

    become transparent, and the system will be easy to follow and there will be no inter-state tax

    hassles, adds Puri.

    Drug distribution in India is layered and regulated. Unlike in the West, where a manufacturer can

    directly supply goods at the retail level, products in India move through a chain of intermediaries.

    Software based systems for CFAs/Depots/Distributors

    Pharma CFA

    Pharma CFA has been exclusively developed for the pharmaceutical industry,whose distribution is routed through CFAs, depots and distributors. It simulates

    the distribution activities of a CFA, depotor a distributor and takes care of the

    daily, monthly and yearly activities of stock accounting, order processing and

    customer accounting. It also provides for immediate querying and extensive reporting

    facilities. This robust software package helps the users to have a greater control and

    up-to-date information on the status of stock, orders, customers, and so on.

    Features of Pharma CFA

    Supports multiple Company/Divisions.

  • 8/8/2019 CFAs_0920202

    2/2

    User-definable Parameters like:

    Debit Note, Credit Note Types

    Positive/Negative Stock Adjustment Types

    Sales Area/Staff Hierarchy

    Sales Targets at Area Level

    Stock allocation on FIFO basis

    Stock Maintenance at Product/Price/Batch Level

    Order wise-Product wise Allocations

    Product wise-Order wise Allocations

    Flexible Bonus Schemes

    Pooled Sales Area Support

    Flexible Tax, Discount, Octroi Definition Partial Adjustments in Customer Accounting

    Automatic/Manual Debit Notes Generation

    Exhaustive Queries/Reports

    User and Option Level Security

    User-friendly, Multi-level, Context Sensitive Help Support

    Modules of Pharma CFA

    Masters

    Daily Operations

    Stock Accounting

    Order Processing

    Queries

    Reports

    House Keeping